Related Experiment Video
Updated: Jul 17, 2025

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016
Short-pulse laser plus subthreshold diffuse laser for serous retinal detachment in dome-shaped macula
Murilo Wendeborn Rodrigues1, Thais Bastos2, Annelise Nicotti Gonçalves2
1Division of Ophthalmology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil. murilowrj@yahoo.com.br.
This study shows that a combined laser treatment effectively reduces subretinal fluid and improves vision in dome-shaped macula patients with serous retinal detachment. The treatment demonstrated significant anatomical and functional improvements one year post-procedure.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Medical Technology
Background:
- Dome-shaped macula (DSM) is characterized by an anterior convex protrusion of the macula.
- Visual impairment in DSM often results from sub-foveal serous retinal detachment (SRD).
- Current treatments focus on addressing SRD to improve visual function.
Purpose of the Study:
- To evaluate the anatomical and functional outcomes of a combined laser treatment for SRD in patients with DSM.
- To assess the efficacy of Pascal® short-pulse (SP) laser combined with endpoint management (EpM) subthreshold diffuse laser (SDL).
Main Methods:
- Retrospective analysis of seven consecutive patients (eight eyes) with SRD secondary to DSM.
- Ophthalmological evaluation including visual acuity (BCVA) and spectral-domain optical coherence tomography (SD-OCT).
- Treatment involved combined Pascal® SP laser plus EpM-SDL, with follow-up intervals of 1-6 months and a mean follow-up of 12.92 months.
Main Results:
- Significant reduction in central subfield thickness (CST) from 412.50 µm to 294.75 µm (p=0.0078).
- Significant improvement in best-corrected visual acuity (BCVA) from 0.6125 LogMAR to 0.4537 LogMAR (p=0.0313).
- Mean SRD resolution time was 3.75 months, with no adverse events reported.
Conclusions:
- The combined Pascal® SP laser plus EpM-SDL treatment is a novel modality for managing SRD in DSM patients.
- This treatment can induce subretinal fluid regression and improve BCVA within one year.
- The procedure demonstrated safety and efficacy in the studied patient cohort.
More Related Videos
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
11:03Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018